|Articles|May 1, 2019
- Pharmaceutical Executive-05-01-2019
- Volume 39
- Issue 5
Pharmaceutical Executive, May 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Impact Investing and R&Dover 7 years ago
New Flare-Up in Europe's External Reference Pricing Debateover 7 years ago
It’s Time for a Chief Adherence Officerover 7 years ago
Adopting New Technology: Barriers and Breakthroughsover 7 years ago
The CFO Evolutionover 7 years ago
We’ve Got You Coveredover 7 years ago
Survey Spotlights the CFO’s Strategic Riseover 7 years ago
FDA After Gottlieb: Thorny Issues, Political Challengesover 7 years ago
Easing the Path to Profitabilityover 7 years ago
A Strategic Approach to Pharma R&D Portfolio PlanningAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
2
What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates
3
The Current Status of the 340B Program
4
U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report
5